Cambridge Investment Research Advisors Inc. trimmed its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 2.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,184 shares of the company’s stock after selling 1,391 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Express Scripts Holding were worth $3,114,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Park National Corp OH lifted its holdings in Express Scripts Holding by 0.3% during the 2nd quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after buying an additional 11 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in Express Scripts Holding by 0.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after buying an additional 23 shares during the last quarter. Carroll Financial Associates Inc. lifted its holdings in Express Scripts Holding by 1.0% during the 2nd quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock worth $203,000 after buying an additional 30 shares during the last quarter. CAPROCK Group Inc. lifted its holdings in Express Scripts Holding by 0.9% during the 2nd quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after buying an additional 33 shares during the last quarter. Finally, Sandy Spring Bank lifted its holdings in Express Scripts Holding by 0.6% during the 2nd quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock worth $413,000 after buying an additional 37 shares during the last quarter. 89.44% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Cambridge Investment Research Advisors Inc. Has $3.11 Million Position in Express Scripts Holding Company (ESRX)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/18/cambridge-investment-research-advisors-inc-has-3-11-million-position-in-express-scripts-holding-company-esrx.html.

In related news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $63.93, for a total value of $249,327.00. Following the sale, the director now owns 11,500 shares in the company, valued at approximately $735,195. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Everett Neville sold 1,163 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total value of $71,501.24. Following the completion of the sale, the vice president now owns 18,232 shares in the company, valued at approximately $1,120,903.36. The disclosure for this sale can be found here. Insiders have sold a total of 6,284 shares of company stock worth $397,421 in the last quarter. 0.68% of the stock is currently owned by insiders.

Express Scripts Holding Company (ESRX) traded down $0.51 during midday trading on Friday, reaching $61.94. The company’s stock had a trading volume of 3,022,050 shares, compared to its average volume of 4,096,019. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. Express Scripts Holding Company has a 52 week low of $55.80 and a 52 week high of $77.50. The firm has a market cap of $34,010.00, a PE ratio of 8.81, a price-to-earnings-growth ratio of 0.89 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last released its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. Express Scripts Holding had a return on equity of 25.46% and a net margin of 3.64%. The company had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. During the same quarter in the previous year, the firm posted $1.74 EPS. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. research analysts predict that Express Scripts Holding Company will post 7.01 earnings per share for the current year.

A number of brokerages have issued reports on ESRX. Robert W. Baird reaffirmed a “hold” rating and set a $56.00 price target on shares of Express Scripts Holding in a report on Friday, September 1st. Jefferies Group LLC reissued a “buy” rating on shares of Express Scripts Holding in a report on Thursday, October 26th. Zacks Investment Research raised Express Scripts Holding from a “hold” rating to a “buy” rating and set a $64.00 target price for the company in a report on Monday, October 16th. Morgan Stanley boosted their target price on Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a report on Thursday, August 10th. Finally, Needham & Company LLC assumed coverage on Express Scripts Holding in a report on Friday, July 21st. They issued a “hold” rating for the company. Seven analysts have rated the stock with a sell rating, ten have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $69.53.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.